The characterisation of three substituted zinc phthalocyanines of differing charge for use in photodynamic therapy. A comparative study of their aggregation and photosensitising ability in relation to mTHPC and polyhaematoporphyrin

Journal of Photochemistry and Photobiology B: Biology

Volumn 45, Issue 1, 1998, Pages 28-35

  Ball, Denise J ^a   Wood, Simon R ^a   Vernon, David I ^a   Griffiths, John ^a   Dubbelman, Tom M A R ^b   Brown, Stanley B ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Photodynamic therapy; Photosensitizers; Phthalocyanines

Indexed keywords

BOVINE SERUM ALBUMIN; HEMATOPORPHYRIN; HISTIDINE; METHANOL; MONOMER; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TRYPTOPHAN;

AQUEOUS SOLUTION; ARTICLE; COMPARATIVE STUDY; DRUG PROTEIN BINDING; DRUG STRUCTURE; OXYGEN CONSUMPTION; PHOTODYNAMIC THERAPY; PHOTOOXIDATION; PHOTOSENSITIZATION; PRIORITY JOURNAL;

ANIMALS; CATTLE; ERYTHROCYTES; HISTIDINE; HUMANS; INDOLES; METHANOL; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; OXIDATION-REDUCTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SERUM ALBUMIN, BOVINE; TRYPTOPHAN;

EID: 0032555492     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00156-0     Document Type: Article

References (35)

1. [1] T.J. Dougherty, Yearly review. Photodynamic therapy, Photochem. Photobiol. 58 (1993) 895-900.
2. [2] J.J. Schuitmaker, P. Bass, H.L.L.M. van Leengoed, F.W. van der Meulen, W.M. Star, N. van Zandwijk, Photodynamic therapy: apromising new modality for the treatment of cancer, J. Photochem. Photobiol. B: Biol. 34 (1996) 3-12.
3. [3] D.I. Vernon, J.A. Holroyd, S.M. Stribbling, S.B. Brown, The quantitative determination of Photofrin and polyhaematoporphyrin in plasma: pitfalls and inaccuracies, J. Photochem. Photobiol. B: Biol. 27 (1995) 209-217.
4. [4] B.W. Henderson, T.J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol. 55 (1992) 145-157.
5. [5] J. Moan, Properties for optimal PDT sensitizers, J. Photochem. Photobiol. B: Biol. 5 (1990) 521-524.
6. [6] J.D. Spikes, Chlorins as photosensitizers in biology and medicine, J. Photochem. Photobiol. B: Biol. 6 (1990) 259-274.
7. [7] A.R. Morgan, Reduced porphyrins as photosensitizers: synthesis and biological effects, in: B.W. Henderson, T.J. Dougherty (Eds.), Photodynamic Therapy Basic Principles and Clinical Applications, Marcel Dekker, New York, 1994, pp. 157-172.
8. [8] G.M. Garbo, Purpurins and benzochlorins as sensitizers for photodynamic therapy, J. Photochem. Photobiol. B: Biol. 34 (1996) 109-116.
9. [9] E. Ben-Hur, Photochemistry and photobiology of phthalocyanines: new photosensitizers for photodynamic therapy of cancer, Photobiochem. Photobiophys. Suppl. (1987) 407-420.
10. [10] J.E. van Lier, J.D. Spikes, The chemistry, photophysics and photosensitizing properties of phthalocyanines, in: Photosensitizing Compounds: their Chemistry, Biology and Clinical Use, Ciba Foundation Symp. 146, Wiley, Chichester, UK, 1989, pp. 17-32.
11. [11] I. Rosenthal, Phthalocyanines as photodynamic sensitizers, Photochem. Photobiol. 53 (1991) 859-870.
12. [12] E. Ben-Hur, Basic photobiology and mechanisms of action of phthalocyanines, in: B.W. Henderson, T.J. Dougherty (Eds.), Photodynamic Therapy Basic Principles and Clinical Applications, Marcel Dekker, New York, 1994, pp. 63-77.
13. [13] R. Bonnett, M. Berenbaum, Porphyrins as photosensitizers, in: Photosensitizing Compounds: their Chemistry, Biology and Clinical Use, Ciba Foundation Symp. 146, Wiley, Chichester, UK, 1989, pp. 40-53.
14. [14] M.C. Berenbaum, R. Bonnett, E.B. Cheveretton, S.L. Akande-Adebakin, M. Ruston, Selectivity of meso-tetra(hydroxyphenyl)-porphyrins and chlorins and of Photofrin II in causing photodamage in tumour, skin, muscle and bladder. The concept of cost-benefit in analysing the results, Lasers Med. Sci. 8 (1993) 235-243.
15. [15] R. Bonnett, R.D. White, U.-J. Winfield, M.C. Berenbaum, Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizes, Biochem. J. 261 (1989) 277-280.
16. [16] L.W. Ma, J. Moan, K. Berg, Comparison of the photobleaching effect of three photosensitizing agents: meso-tetra(m-hydroxyphenyl)-chlorin, meso-tetra(m-hydroxyphenyl)porphyrin and Photofrin during photodynamic therapy, Lasers Med. Sci. 9 (1994) 127-132.
17. [17] D. Braichotte, G. Wagnières, J.-M. Philippoz, R. Bays, H.-B. Ris, H. van den Bergh, Preliminary clinical results on a second generation photosensitizer: mTHPC, in: P. Spineeli, M. Dal Fante, R. Marchesini (Eds.), Photodynamic Therapy and Biomedical Lasers, Elsevier, Amsterdam, 1992, pp. 461-465.
18. [18] J.R. Darwent, P. Douglas, A. Harriman, G. Porter, M.-C. Richoux, Metal phthalocyanines and porphyrins as photosensitizers for reduction of water to hydrogen, Co-ordin. Chem. Rev. 44 (1982) 83-126.
19. [19] G. Valduga, E. Reddi, G. Jori, Spectroscopic studies on zinc (II)-phthalocyanine in homogeneous and microheterogeneous systems, J. Inorg. Biochem. 29 (1987) 59-65.
20. [20] J. Griffiths, J. Schofield, M. Wainwright, S.B. Brown, Some observations on the synthesis of polysubstisuted zinc phthalocyanine sensitisers for photodynamic therapy, Dyes and Pigments 33 (1997) 65-78.
21. [21] J. Griffiths, J. Cruse-Sawyer, S.R. Wood, J. Schofield, S.B. Brown, B. Dixon, On the photodynamic therapy action of zinc phthalocyanine tetrasulphonic acid in vivo, J. Photochem. Photobiol. B: Biol. 24 (1994) 195-199.
22. [22] J.E. Cruse-Sawyer, J. Griffiths, B. Dixon, S.B. Brown, The photodynamic response of two rodent tumour models to four zinc (II)-substituted phthalocyanines, Br. J. Cancer 77 (1997) 965-972.
23. [23] E. Kohen, R. Santus, J.G. Hirschberg, Photochemistry of biological molecules, in: Photobiology, Academic Press, London, 1995, pp. 97-116.
24. [24] T.M.A.R. Dubbelman, C. Prinsze, L.C. Penning, J. van Steveninck, Photodynamic therapy: membrane and enzyme photobiology, in: B.W. Henderson, T.J. Dougherty (Eds.), Photodynamic Therapy Basic Principles and Clinical Applications, Marcel Dekker, New York, 1992, pp. 37-54.
25. [25] S.B. Brown, M. Shillcock, Equilibrium and kinetic studies on the aggregation of porphyrins in aqueous solution, Biochem. J. 153 (1976) 279-285.
26. [26] B.M. Aveline, T. Hasan, R.W. Redmond, The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA), J. Photochem. Photobiol. B: Biol. 30 (1995) 161-169.
27. [27] G.S. Timmins, A study of substituted phthalocyanines as potential drugs for photodynamic therapy, Ph.D. Thesis, Department of Biochemistry and Molecular Biology, University of Leeds ( 1990).
28. [28] L. Ma, J. Moan, K. Berg, Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers, Int. J. Cancer 57 (1994) 883-888.
29. [29] C.S. Foote, Definition of type I and type II photosensitizers, Photochem. Photobiol. 54 (1991) 659.
30. [30] E. Reddi, M.A.J. Rodgers, J.D. Spikes, G. Jori, The effect of medium polarity on the hematoporphyrin-sensitized photoxidation of L-tryptophan, Photochem. Photobiol. 40 (1984) 415-421.
31. [31] D.M. Fiedler, F. Wierrani, G. Schnitzhofer, J.C.M. Stewart, K. Gharehbaghi, W. Grunberger, B. Krammer, Does the in-vitro efficiency of meso-tetrahydroxy-phenyl-chlorin depend on pre-treatment of sensitizer?, J. Photochem. Photobiol. 38 (1997) 241-244.
32. [32] J.R. Wagner, H. Ali, R. Langlois, J.E. van Lier, Biological activities of phthalocyanines - VI. Photoxidation of L-tryptophan by selectively sulfonated gallium phthalocyanines: singlet oxygen yields and effect of aggregation, Photochem. Photobiol. 45 (1987) 87-594.
33. [33] T.M.A.R, Dubbelman, A.F.P.M. De Goeij, J. van Steveninck, Protoporphyrin-induced photodynamic effects on transport processes across the membrane of human erythrocytes, Biochim. Biophys. Acta 595 (1980) 133-139.
34. [34] B. Deuticke, U. Henseleit, C.W.M. Haest, K.B. Heller, T.M.A.R. Dubbelman, Enhancement of transbilayer mobility of a membrane lipid probe accompanies formation of membrane leaks during photodynamic treatment of erythrocytes, Biochim. Biophys. Acta 982 (1989) 53-61.
35. [35] M. Sonoda, C.M. Krishna, P. Riesz, The role of singlet oxygen in the photohemolysis of red blood cells sensitized by phthalocyanine sulfonates, Photochem. Photobiol. 46 (1987) 625-631.